U.S. Market for Fetal and Neonatal Monitoring Devices
Abstract:
Fetal and neonatal monitoring are similar, but they differ in the time in the pregnancy and birthing cycle when each device is used. Fetal monitoring occurs before and during the birthing process, while neonatal monitoring occurs after birth. Moreover, the parameters that are most important to be monitored vary depending on the stage of pregnancy. The growth and development of the fetus is important to monitor in antepartum situations in an attempt to detect complications such as intrauterine growth retardation and other malformations. Closer to labor, it is important to monitor fetal distress. After birth, it is important to monitor all physiological processes in order for physicians to take immediate, appropriate actions in the event of complications.
Scope of Report: This report pertains to a forecast period of 10 years (2009 – 2019) for the U.S. Market.
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
Fetal and neonatal monitoring are similar, but they differ in the time in the pregnancy and birthing cycle when each device is used. Fetal monitoring occurs before and during the birthing process, while neonatal monitoring occurs after birth. Moreover, the parameters that are most important to be monitored vary depending on the stage of pregnancy. The growth and development of the fetus is important to monitor in antepartum situations in an attempt to detect complications such as intrauterine growth retardation and other malformations. Closer to labor, it is important to monitor fetal distress. After birth, it is important to monitor all physiological processes in order for physicians to take immediate, appropriate actions in the event of complications.
Scope of Report: This report pertains to a forecast period of 10 years (2009 – 2019) for the U.S. Market.
- Competitor Analysis
- Identified Strategic Opportunities
- Market Overview by Segment
- Trend Analysis by Segment
- Market Drivers & Limiters
- Mergers & Acquisitions
- Customer Feedback & Market Monitoring
- PROCEDURES
- FEMALE AND NEONATAL DIAGNOSTIC DEVICES MARKET OVERVIEW
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
U.S. MARKETS FOR FEMALE AND NEONATAL DIAGNOSTIC DEVICES
1.1MARKET INTELLIGENCE SUITE BREAKDOWN
FULL SUITE EXECUTIVE SUMMARY
2.1 U.S. FEMALE AND NEONATAL DIAGNOSTIC DEVICE MARKET
2.2 GROWTH TRENDS
2.3 PROCEDURES
2.4 BONE DENSITOMETRY MARKET
2.5 BREAST BIOPSY DEVICE MARKET
2.6 BREAST IMAGING MARKET
2.7 OBSTETRICS AND GENECOLOGY ULTRASOUND MARKET
2.8 FETAL AND NEONATAL MONITORING MARKET
2.9 INFANT WARMER AND INCUBATOR MARKET
2.10 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
3.1 RESEARCH SCOPE
3.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
PROCEDURES
4.1 BREAST BIOPSY PROCEDURES
4.2 BREAST IMAGING PROCEDURES
4.3 OBSTETRICS AND GYNECOLOGY ULTRASOUND PROCEDURES
4.4 LUMPECTOMY PROCEDURES
4.5MASTECTOMY PROCEDURES
4.6 BREAST CANCER INCIDENCE
4.7 OVARIAN CANCER DIAGNOSES
BREAST TOMOSYNTHESIS MARKET OVERVIEW
5.1 INTRODUCTION
5.2MARKET ANALYSIS AND FORECAST
5.2.1 Approximate Market Value
5.2.2 ASP and Competition
5.2.3 Reimbursement
5.2.4 Installed Base
5.2.5 Sales Concentration and Procedure Numbers
5.3 DRIVERS AND LIMITERS
5.3.1 Market Drivers
5.3.2 Market Limiters
5.4 COMPETITIVE ANALYSIS
ABBREVIATIONS
1.1MARKET INTELLIGENCE SUITE BREAKDOWN
FULL SUITE EXECUTIVE SUMMARY
2.1 U.S. FEMALE AND NEONATAL DIAGNOSTIC DEVICE MARKET
2.2 GROWTH TRENDS
2.3 PROCEDURES
2.4 BONE DENSITOMETRY MARKET
2.5 BREAST BIOPSY DEVICE MARKET
2.6 BREAST IMAGING MARKET
2.7 OBSTETRICS AND GENECOLOGY ULTRASOUND MARKET
2.8 FETAL AND NEONATAL MONITORING MARKET
2.9 INFANT WARMER AND INCUBATOR MARKET
2.10 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
3.1 RESEARCH SCOPE
3.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
PROCEDURES
4.1 BREAST BIOPSY PROCEDURES
4.2 BREAST IMAGING PROCEDURES
4.3 OBSTETRICS AND GYNECOLOGY ULTRASOUND PROCEDURES
4.4 LUMPECTOMY PROCEDURES
4.5MASTECTOMY PROCEDURES
4.6 BREAST CANCER INCIDENCE
4.7 OVARIAN CANCER DIAGNOSES
BREAST TOMOSYNTHESIS MARKET OVERVIEW
5.1 INTRODUCTION
5.2MARKET ANALYSIS AND FORECAST
5.2.1 Approximate Market Value
5.2.2 ASP and Competition
5.2.3 Reimbursement
5.2.4 Installed Base
5.2.5 Sales Concentration and Procedure Numbers
5.3 DRIVERS AND LIMITERS
5.3.1 Market Drivers
5.3.2 Market Limiters
5.4 COMPETITIVE ANALYSIS
ABBREVIATIONS
